Rapid thrombophilia genetic test facilitates improved prenatal care for mother and child

South African Family Practice

Volumn 47, Issue 7, 2005, Pages 50-51

  Kotze, Maritha J ^a,d   La Grange, C ^b   Mansvelt, E P G ^c  

^a Christiaan Barnard Memorial Hospital   (South Africa)

^b Louis Leipoldt Medi Clinic   (South Africa)

^c STELLENBOSCH UNIVERSITY   (South Africa)

^d NONE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 5 LEIDEN; HOMOCYSTEINE; PROTHROMBIN;

ALLELE; BLEEDING; DELIVERY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; GENETIC MARKER; HUMAN; HYPERHOMOCYSTEINEMIA; MATERNAL MORTALITY; NEURAL TUBE DEFECT; PREGNANCY; PREGNANT WOMAN; PRENATAL CARE; RISK ASSESSMENT; RISK FACTOR; SHORT SURVEY; SYMPTOMATOLOGY; THROMBOPHILIA; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

EID: 27244437772     PISSN: 20786190     EISSN: 20786204     Source Type: Journal    
DOI: 10.1080/20786204.2005.10873264     Document Type: Short Survey

References (17)

1. Vergotine J, Thiart R, Langenhoven E, Hillermann R, de Jong G, Kotze MJ. Prenatal diagnosis of familial hypercholesterolemia: Importance of DNA analysis in the high-risk South African population. Genet Counsel 2001; 12: 121-127.
2. Kotze MJ, Kriegshäuser G, Thiart R, de Villiers JNP, Scholtz CL, Kury F, Moritz A, Oberkanins C. Simultaneous detection of multiple familial hypercholesterolaemia mutations facilitates an improved diagnostic service in South African patients at high risk of cardiovascular disease. Mol Diagn 2003; 7: 169-174.
3. Kotze MJ, Thiart R. Genetics of dyslipidaemia. CME J 2003; 21: 399-402.
4. Grandone E, Margaglione M, Colaizzo D, Cappucci G, Brancaccio V, Di Minno G. Gene susceptibility to pregnancy-related venous thromboembolism: Roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations. Am J Obstet Gynaecol 1997; 179: 1324-1328.
5. Brenner B. Inherited thrombophilia and pregnancy loss. Thromb Haemost 1999; 82: 634-640.
6. Dossenbach-Glaninger A, van Trotsenburg M, Dossenbach M, Oberkanins C, Moritz A, Krugluger W, Huber J, Hopmeier P. Plasminogen activator inhibitor-1 4G/5G polymorphism and coagulation factor XIII Val34Leu polymorphism: Impaired fibrinolysis and early pregnancy loss. Clin Chem 2003; 49: 1081-1086.
7. Kirke PN, Mills JL, Molloy AM, Brody LC, O'Leary VB, Daly L, Murray S, Conley M, Mayne PD, Smith O, Scott JM. Impact of the MTHFR C677T polymorphism on risk of neural tube defects: a case-control study. Br Med J 2004; 328: 1535-1536.
8. Scholtz CL, Odendaal HJ, Thiart R, Loubser L, Hillermann R, Delport R, Vermaak WJH, Kotze MJ. Analysis of two mutations in the MTHFR gene associated with mild hyperhomocysteinaemia: Heterogeneous distribution across ethnic groups. S Afr Med J 2002; 92: 464-467.
9. Kosmas IP, Tatsioni A, loannidis JP. Association of C677T polymorphism in the methylenetetrahydrofolate reductase gene with hypertension in pregnancy and pre-eclampsia: a meta-analysis. J Hypertens 2004;22:1655-1662.
10. Glueck CJ, Wang P, Fontaine RN, Sieve-Smith L, Tracy T, Moore SK. Plasminogen activator inhibitor activity: an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome. Metabolism 1999; 48: 1589-1595.
11. Glueck CJ, Phillips H, Cameron D, Wang P, Fontaine RN, Moore SK, Sieve-Smith L, Tracy T. The 4G/5G polymorphism of the hypofibrinolytic plasminogen activator inhibitor type 1 gene: an independent risk factor for serious pregnancy complications. Metabolism 2000; 49: 845-852.
12. Kotze MJ, Badenhorst H. Chronic disease risk management: Combining genetic testing with medical and nutrition therapy. SA Fam Pract 2005; 47: 40-42.
13. Brenner B, Grabowski EF, Hellgren M, Kenet G, Massicotte P, Manco-Johnson M, Mathew P, Muntean W, Schlegel N, Nowak-Gottl U. Thrombophilia and pregnancy complications. Thromb Haemost 2004; 92: 678-681.
14. Deol PS, Barnes TA, Dampier K, John Pasi K, Oppenheimer C, Pavord SR. The effects of folic acid supplements on coagulation status in pregnancy. Br J Haematol 2004; 127: 204-208.
15. De Bree A, van Dusseldorp M, Brouwer IA, van het Hof KH, Steegers-Theunissen RP. Folate intake in Europe: recommended, actual and desired intake. Eur J Clin Nut 1997; 5: 643-60.
16. Wald NJ, Law MR, Morris JK, Wald DS. Quantifying the effect of folic acid. Lancet 2001; 358: 2069-73.
17. Gallus AS. Management options for thrombophilias. Semin Thromb Hemost. 2005; 31: 118-26.